缩乳成形术先行可降低大乳房患者保留乳头乳晕乳房切除术后缺血并发症
研究纳入2016至2024年接受保留乳头乳晕乳房切除术(NSM)联合即刻DIEP皮瓣再造、原生罩杯D及以上的患者,比较术前缩乳成形组(21例39侧)与对照组(29例51侧)。缩乳组皮肤坏死(5.1% vs 37.3%,P<0.001)和乳头乳晕复合体(NAC)坏死(2.6% vs 21.6%,P=0.011)显著更低,多因素回归显示缩乳成形是皮肤和NAC坏死的显著保护因素。
要点
- 大乳房患者NSM联合DIEP再造前先行缩乳成形,与皮肤坏死和NAC坏死风险显著降低相关。
- 缩乳组皮肤坏死5.1% vs 对照组37.3%(P<0.001),NAC坏死2.6% vs 21.6%(P=0.011)。
- 多因素回归中缩乳成形使皮肤坏死和NAC坏死风险分别降低93.8%和90.8%。
核心结论
- 术前缩乳成形与大乳房患者NSM联合DIEP皮瓣再造后缺血并发症减少相关。
研究设计与样本
- 回顾性队列研究,纳入2016至2024年接受NSM联合即刻DIEP皮瓣再造、原生罩杯D及以上的患者。
- 缩乳组21例(39侧乳房),对照组29例(51侧乳房),两组术前平均罩杯均为DD。
主要发现
- 缩乳组皮肤坏死发生率为5.1%,对照组为37.3%(P<0.001)。
- 缩乳组NAC坏死发生率为2.6%,对照组为21.6%(P=0.011)。
- 缩乳组感染率为5.1%,对照组为19.6%(P=0.061),接近统计学显著。
- 多因素回归显示缩乳成形是皮肤坏死的显著保护因素(β=-2.774,P=0.002),风险降低93.8%。
- 多因素回归显示缩乳成形是NAC坏死的显著保护因素(β=-2.385,P=0.030),风险降低90.8%。
关键数值与推荐
- 缩乳组中41.0%接受计划性分期缩乳,平均间隔4.63个月;59.0%有既往择期缩乳史,平均间隔13.35年。
临床怎么用
- 对大乳房(罩杯D及以上)拟行NSM联合DIEP再造的患者,可考虑术前先行缩乳成形以降低缺血并发症风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nipple-sparing mastectomy (NSM) improves aesthetic outcomes but carries a higher risk of ischemic complications, particularly in patients with large, ptotic breasts. This study evaluates whether reduction mammaplasty prior to NSM with deep inferior epigastric perforator (DIEP) flap reconstruction can help mitigate these risks. METHODS: All patients who underwent NSM with immediate DIEP flap reconstruction between 2016 and 2024 were identified. Only those with native breast cup size D or larger were included. Patients were divided into 2 cohorts: those who underwent reduction mammaplasty prior to NSM (reduction cohort) and those without prior breast surgery (control cohort). RESULTS: The reduction group included 21 patients (39 breasts), and the control group included 29 patients (51 breasts). Both groups had an average preoperative breast cup size of DD. Within the reduction group, 41.0% underwent planned staged reductions (average interval, 4.63 months), whereas 59.0% had prior elective reductions (average interval, 13.35 years). Postoperatively, the reduction group experienced significantly lower rates of skin necrosis (5.1% vs 37.3%, P < 0.001) and nipple-areolar complex (NAC) necrosis (2.6% vs 21.6%, P = 0.011). Infection rates were also lower, approaching statistical significance (5.1% vs 19.6%, P = 0.061). On multivariate regression, reduction mammaplasty was a significant protective factor against both skin ( β = -2.774, P = 0.002) and NAC necrosis ( β = -2.385, P = 0.030), reducing the odds by 93.8% and 90.8%, respectively. CONCLUSION: Our findings suggest that prior reduction mammaplasty is associated with decreased ischemic complications in large-breasted patients undergoing NSM and DIEP flap reconstruction.
引用
- Qin N, Dugue D, Gundlach C, et al. Reduction Mammaplasty Prior to Nipple-Sparing Mastectomy Is Associated With Decreased Ischemic Complications in Large-Breasted Patients. Ann Plast Surg. 2026. PMID: 41662666. doi:10.1097/SAP.0000000000004661
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。